US SB272

Manufacturers must notify the FDA within 1 business day of confirmed positive test results for microorganisms in finished infant formula products, regardless of whether the product has left the facility

FDA must respond to contamination notifications within 1 business day to begin investigation discussions, and must confirm within 90 days that manufacturers performed appropriate corrective actions

Manufacturers must provide test results, isolates, or whole genome sequence data from positive samples and consult with FDA on proper isolation and disposal of affected products

FDA must issue a progress report within 180 days on implementing recommendations from the January 2025 "Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market" and submit quarterly supply chain reports for 5 years

FDA must submit reports at 1, 3, and 5 years on evidence-based practices to maximize infant formula supply and safety, including the value of high-frequency testing for identifying contamination events involving botulism or other contaminants